From GlobeNewswire:

Brian Foard, an experienced leader in the healthcare industry, has been appointed to lead Sanofi’s global commercial entity, Médecine de Spécialités. Effective immediately, Foard has also been named a member of Sanofi’s executive committee. Previously serving as Head of Specialty Medicine North America, and Director of Sanofi’s U.S. operations, Foard’s more than two decades of expertise include spearheading the successful launch of Dupixent® in over fifty countries for various age groups and indications. Sanofi’s CEO, Paul Hudson expressed excitement about Foard’s appointment, stating that they are looking forward to his leadership for Sanofi’s immunology mission. Foard, an East Carolina University alumnus, is based in Cambridge, Massachusetts.



Read more: Brian Foard est nommé Responsable de